Combined with our current findings on CIN/CNAs associated with STIL overexpression via centrosome amplification in NSCLC, we hypothesize that STIL overexpression is strongly linked to malignant tumor progression, tumor heterogeneity, and drug resistance (Supplementary Figure S5). The gene discussed is STIL; the disease is cancer.